UPB
Upstream Bio Inc.

99
Loading...
Loading...
Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin. The company was founded in April 2021 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
52

Frequently Asked Questions

What is Market Cap of Upstream Bio Inc.?
What is the 52-week high for Upstream Bio Inc.?
What is the 52-week low for Upstream Bio Inc.?
What is Upstream Bio Inc. stock price today?
What was Upstream Bio Inc. stock price yesterday?
What is the PE ratio of Upstream Bio Inc.?
What is the Price-to-Book ratio of Upstream Bio Inc.?
What is the 50-day moving average of Upstream Bio Inc.?
How many employess does Upstream Bio Inc. has?

Latest UPB News

View

Advertisement. Remove ads.

Advertisement. Remove ads.